Last reviewed · How we verify

SEVOFLURANE — Competitive Intelligence Brief

SEVOFLURANE (SEVOFLURANE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: General Anesthetic [EPC].

marketed General Anesthetic [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

SEVOFLURANE (SEVOFLURANE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SEVOFLURANE TARGET SEVOFLURANE marketed General Anesthetic [EPC] 1995-01-01
Suprane DESFLURANE Baxter marketed General Anesthetic [EPC] GABA-A receptor; anion channel 1992-01-01
Diprivan Propofol Fresenius Kabi marketed General anesthetic GABA A receptors 1989-01-01
PROPOFOL PROPOFOL marketed General Anesthetic [EPC] 1989-01-01
Amidate ETOMIDATE Pfizer marketed General Anesthetic [EPC] Cytochrome P450 11B2, mitochondrial 1982-01-01
Forane ISOFLURANE Baxter marketed General Anesthetic [EPC] 5-hydroxytryptamine receptor 2B 1979-01-01
Efrane ENFLURANE Baxter marketed General Anesthetic Glycine receptor subunit alpha-1 1972-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (General Anesthetic [EPC] class)

  1. · 2 drugs in this class
  2. Baxter · 2 drugs in this class
  3. Pfizer · 1 drug in this class
  4. Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SEVOFLURANE — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: